For Patients & Caregivers
Tell your healthcare providers about any dietary supplements you’re taking, such as herbs, vitamins, minerals, and natural or home remedies. This will help them manage your care and keep you safe.
What is it?
What is it used for?
CoQ10 is used to:
- Prevent heart disease
- Reduce cholesterol
- Reduce muscle pain caused by cholesterol medications known as statins
- Prevent migraines
- Help reduce symptoms of Parkinson’s disease
- Treat infertility
CoQ10 also has other uses that haven’t been studied by doctors to see if they work.
CoQ10 is generally safe. But supplements can interact with some medications and affect how they work. For more information, read the “What else do I need to know?” section below.
What are the side effects?
What else do I need to know?
- Talk to your doctor if you’re on chemotherapy or radiation therapy. CoQ10 may affect how these treatments work and can make them less effective.
- Talk to your doctor if you’re taking blood thinners such as warfarin (Coumadin®). CoQ10 may increase your risk of bleeding if you take it with blood thinners.
- Talk to your doctor if you’re on theophylline (Theolair®) for asthma or other lung problems, such as emphysema (when air sacs in your lungs are damaged) or chronic bronchitis. CoQ10 may affect how this medication works.
For Healthcare Professionals
Coenzyme Q10 (CoQ10), also known as ubiquinone, is involved in cellular respiration and energy production. It is found in all human cells, with higher concentrations found in the liver, kidney, heart, and pancreas. It is also consumed as a dietary supplement for its antioxidant effects and is often promoted as a preventive agent for cardiovascular diseases, Parkinson’s disease, infertility, and cancer. Studies using murine models suggest antioxidant and neuroprotective effects (17) (18), and the potential to alleviate radiation-induced nephropathy (34).
Data from some human studies suggest CoQ10 may benefit patients with coronary artery disease (2) and congestive heart failure (21), and reduce risk of cardiovascular mortality (46). Other studies using a combination of selenium and CoQ10 also suggest improved cardiac function and reduced mortality risk (43) (47) (58). However, a systematic review concluded that current evidence does not support routine CoQ10 supplementation in patients with coronary heart disease (42).
Observations that patients on statins have decreased CoQ10 concentrations in muscle cells (25) resulted in efforts to evaluate CoQ10 for statin-induced myalgias, but data are inconclusive (26) (27) (28) (45) (52). Short-term CoQ10 supplementation in diabetic hemodialysis patients improved markers of insulin metabolism, but not fasting glucose, HbA1c, or lipid profiles (48). A meta-analysis concluded that evidence of benefit in diabetic kidney disease is limited and additional study is needed (49).
CoQ10 may be helpful in some cases for migraine prevention (22). A small study found reduced migraine frequency following supplementation (23), and other data suggest it may reduce number of migraine days and duration, but not number of attacks or severity (50). A randomized trial of add-on supplementation in pediatric migraine failed to find benefit (24).
Although neuroprotective effects have been reported in small trials (5) (6) (33), larger well-designed trials have not shown benefit with CoQ10 supplementation in Parkinson’s (7) (59) or Huntington’s disease (51). In other studies, adjuvant CoQ10 improved depressive symptoms in patients with bipolar disorder (44), but an antioxidant mixture including CoQ10, vitamins C and E, and alpha-lipoic acid was ineffective against Alzheimer’s disease (20).
Some data suggest CoQ10 supplementation may increase sperm motility in men (8), modulate expression of insulin, lipid, and inflammatory markers in women with polycystic ovary syndrome (35), and reduce fatigue from physical exertion (9). It may also help reduce reduce some measures of oxidative stress (53) (60) and inflammatory markers in patients with chronic diseases (54). In patients with sepsis, supplementation in the early phase improved clinical parameters and mitochondrial dysfunction (55).
CoQ10 has also been investigated in cancer patients. Preliminary studies on whether it can help control cancer-related fatigue are mixed (29) (38). In patients on tamoxifen therapy, CoQ10 appeared to lower inflammatory cytokine levels (56). CoQ10 levels have been positively associated with antioxidant capacity and negatively correlated with inflammation markers post-surgery in patients with hepatocellular carcinoma (37). However, antioxidant supplementation including CoQ10 before and during treatment was associated with an increased hazard of recurrence in breast cancer patients (57). More research is needed (39).
Mechanism of Action
CoQ10 is known to have antioxidant and membrane-stabilizing properties and is the only endogenously produced lipid with a redox function in mammals. All cells are capable of synthesizing CoQ10 and no redistribution between organs occurs through the blood. It is necessary for adenosine triphosphate (ATP) production, and its role as a mobile electron carrier in the mitochondrial electron-transfer processes of respiration and coupled phosphorylation is well established. It also has a direct regulatory role on succinyl and NADH dehydrogenases (1). CoQ10 scavenges free radicals produced by lipid peroxidation and prevents mitochondrial deformity during ischemic episodes, and may help maintain integrity of myocardial calcium ion channels during ischemic insults (2). CoQ10 may also stabilize cellular membranes and prevent depletion of metabolites required for ATP resynthesis (10), and suppress age-related inflammatory reactions and osteoclast differentiation by inhibiting oxidative stress (30). One of the mechanisms underlying the neuroprotective effects of CoQ10 involves inhibition of microglia in pentylenetetrazol-induced kindling epilepsy in mice (40).
Other preclinical studies suggest CoQ10 can prevent reduced glucose transporter-4 protein levels in adipocytes caused by simvastatin, which may contribute to the risk of new-onset diabetes in patients on statins (31). It also reduced high glucose-induced apoptosis and dysfunction of endothelial progenitor cells by upregulating endothelial nitric oxide synthase and heme oxygenase via the AMP-activated protein kinase pathway (41). In a murine model, it protected against doxorubicin-induced testicular toxicity by ameliorating oxidative stress, reducing apoptosis, and upregulating testicular P-glycoprotein (32).
HMG-CoA reductase inhibitors: Endogenous levels of CoQ10 may be reduced by lovastatin, atorvastatin and simvastatin. The HMG-CoA reductase enzyme is responsible for catalyzing the conversion of acetyl CoA to cholesterol and synthesis of CoQ10 (14).
Warfarin: CoQ10 is structurally similar to vitamin K and may antagonize the effects of warfarin (11). However, CoQ10 has been reported to increase bleeding risk when used with warfarin (12).
Theophylline: CoQ10 delays theophylline clearance, which can cause persistent vomiting, cardiac arrhythmias, and intractable seizures (19).